Related Experiment Videos
Induction of CYP3A4 by 1alpha,25-dyhydroxyvitamin D3 in HepG2 cells
Guillermo Elizondo1, Irma M Medina-Díaz
1Sección Externa de Toxicología, CINVESTAV-IPN, P.O. Box 14-740, México, D.F. 07000, Mexico. gazuela@mail.cinvestav.mx
Abstract:
CYP3A4, the predominant cytochrome P450 (CYP) expressed in human liver, contributes to the metabolism of approximately half the drugs in use today. In general, human-derived cell lines fail to express CYPs. It was previously shown that CYP3A4 mRNA and CYP3A immunoreactive protein are induced by 1alpha,25-dyhydroxyvitamin D(3) (1alpha,25-(OH)(2)D(3)) in the human colon carcinoma cell line Caco-2. The aim of the present study was to examine whether 1alpha,25-(OH)(2)D(3) regulates CYP3A4 gene expression in HepG2 cells, a human hepatocarcinoma cell line. Treatment with 1alpha,25-(OH)(2)D(3) resulted in an induction of CYP3A4 mRNA and CYP3A4 immunoreactive protein, 1.5-fold and 4.0-fold respectively, when compared to control cultures, in a time-dependent fashion. These observations are in agreement with previous reports suggesting a role of 1alpha,25-(OH)(2)D(3) on CYP3A4 transcription regulation, and demonstrate that this hormone, as in Caco-2 cells, increase CYP3A4 levels in HepG2 cells. In conclusion, HepG2 cell cultures treated with 1alpha,25-(OH)(2)D(3), provides a useful model to study the function of CYP3A4 and its role in drug liver metabolism.
Insights
1alpha,25-dihydroxyvitamin D(3) (1alpha,25-(OH)(2)D(3)) significantly increases CYP3A4 mRNA and protein levels in HepG2 cells. This finding establishes HepG2 cells as a valuable model for studying CYP3A4 function in drug metabolism.
Area of Science:
- Pharmacology
- Biochemistry
- Molecular Biology
Background:
- Cytochrome P450 3A4 (CYP3A4) is crucial for metabolizing approximately 50% of current drugs.
- Human-derived cell lines typically lack CYP expression, posing challenges for drug metabolism studies.
- Previous research indicated 1alpha,25-dihydroxyvitamin D(3) (1alpha,25-(OH)(2)D(3)) induces CYP3A4 in Caco-2 cells.
Purpose of the Study:
- To investigate whether 1alpha,25-(OH)(2)D(3) regulates CYP3A4 gene expression in HepG2 cells.
- To determine if HepG2 cells can serve as a model for studying CYP3A4 regulation.
Main Methods:
- HepG2 cells were treated with 1alpha,25-(OH)(2)D(3).
- CYP3A4 mRNA and protein levels were quantified using molecular and immunological techniques.
- Time-dependent effects of the treatment were analyzed.
Main Results:
- Treatment with 1alpha,25-(OH)(2)D(3) led to a time-dependent induction of CYP3A4 mRNA (1.5-fold) and CYP3A4 immunoreactive protein (4.0-fold) in HepG2 cells.
- These results align with prior studies suggesting 1alpha,25-(OH)(2)D(3) influences CYP3A4 transcription.
- The findings confirm that 1alpha,25-(OH)(2)D(3) elevates CYP3A4 levels in HepG2 cells, similar to Caco-2 cells.
Conclusions:
- HepG2 cells treated with 1alpha,25-(OH)(2)D(3) provide a robust in vitro model for studying CYP3A4.
- This model is useful for investigating the role of CYP3A4 in hepatic drug metabolism.
- The study reinforces the regulatory role of 1alpha,25-(OH)(2)D(3) on CYP3A4 expression.